Urinary tract infections in patients with diabetes treated with dapagliflozin
- 31 October 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 27 (5), 473-478
- https://doi.org/10.1016/j.jdiacomp.2013.05.004
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
- AstraZeneca
This publication has 24 references indexed in Scilit:
- SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes MellitusThe Journal of Clinical Pharmacology, 2012
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and ExerciseDiabetes Care, 2010
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatmentInternational Journal of Antimicrobial Agents, 2008
- Risk of Urinary Tract Infection and Asymptomatic Bacteriuria among Diabetic and Nondiabetic Postmenopausal WomenAmerican Journal of Epidemiology, 2005
- Lower genital tract infections in diabetic womenCurrent Infectious Disease Reports, 2002
- Risk factors for symptomatic urinary tract infection in women with diabetes.Diabetes Care, 2000
- Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic StatusJournal of Infection, 2000
- Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group.Diabetes Care, 2000
- Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individualsJournal of Medical Microbiology, 1999